VC Fund Investments
Gut-health focused The Good Bug raises Rs.100-Cr from Susquehanna Asia VC, Fireside
Mumbai-based gut health focused startup The Good Bug has raised INR 100 crore (about USD 12 million) in a Series B funding round led by Susquehanna Asia Venture Capital, an arm of Susquehanna International group. Existing investor Fireside Ventures also participated in the round.The fresh capital will be used to ramp up research & development (R&D) in microbiome science, scale clinical trials, expand distribution, and strengthen brand awareness among both consumers and healthcare professionals.Founded in 2022 by Keshav Biyani and Prabhu Karthikeyan, the company develops probiotic and gut-focused health products targeting digestion, immunity, and metabolic health. The Good Bug last raised USD 4 million in a Series A extension in 2024, led by Sharrp Ventures, the family office of Marico Group’s Harsh Mariwala. The latest fundraise brings its total funding to around USD 20 million.
Want to receive such news items in your inbox? Click Here to sign up for a trial.
